[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355562-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355562-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","b4galnt4-mediated-glycosylation-of-pdk1-activates-the-pi3k-akt-signaling-pathway-to-promote-prostate-cancer-progression","B4GALNT4-Mediated Glycosylation of PDK1 Activates the PI3K-AKT Signaling Pathway to Promote Prostate Cancer Progression","","Abnormal glycosylation is a hallmark of cancer cells and shapes tumor invasion and metastasis, yet the roles of glycogenes in prostate cancer (PCa) are not well defined. This study integrates RNA-seq datasets from TCGA and CPGEA with biochemical validation to pinpoint B4GALNT4. The gene correlates with advanced pathology, higher Gleason scores, and poor prognosis, and acts as an independent survival predictor. B4GALNT4 interacts with PDK1, glycosylating it at N531 to stabilize PDK1 and activate PI3K-AKT signaling, driving PCa proliferation, migration, and invasion in vitro, while knockdown suppresses xenograft growth in vivo.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/b4galnt4-mediated-glycosylation-of-pdk1-activates-the-pi3k-akt-signaling-pathway-to-promote-prostate-cancer-progression/355562/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/b4galnt4-mediated-glycosylation-of-pdk1-activates-the-pi3k-akt-signaling-pathway-to-promote-prostate-cancer-progression/355562.png","ImageObject",300,407,{"name":42,"@type":43},"Taylor Morgan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about prostate cancer?","Question",{"text":63,"@type":64},"The study examines which glycogenes are involved in the onset and progression of prostate cancer and clarifies the molecular mechanisms underlying their roles.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was B4GALNT4 identified as clinically relevant?",{"text":68,"@type":64},"By integrating RNA-seq data from TCGA and CPGEA and performing biochemical validation, B4GALNT4 was found to associate with advanced pathological stages, higher Gleason scores, and poor prognosis, and multivariate Cox regression confirmed it as an independent prognostic factor.",{"name":70,"@type":61,"acceptedAnswer":71},"What mechanism links B4GALNT4 to PI3K-AKT activation?",{"text":72,"@type":64},"B4GALNT4 interacts with PDK1 and glycosylates it at residue N531. This N-glycosylation stabilizes PDK1 by blocking its degradation, thereby activating the PI3K-AKT signaling pathway.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355562,1790308738,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Advanced Science    \n[www.advancedscience.com](www.advancedscience.com)  \n RESEARCH ARTICLE   \nB4GALNT4-Mediated Glycosylation ofPDK1 Activates the PI3K-AKT Signaling Pathway to Promote Prostate Cancer Progression  \nShaoqin Jiang1  Mengqiang Li1  Qingfu Su1  Ruiling Dou1  Shaoshan Lin1  Jili Zhang2  Xiaochen Sun2  Haolan Yu2  Wei Bao2  Min Qu2  Yan Wang2  Chenghua Yang2  Xu Gao2   \n1 Department of Urology, Fujian Union Hospital, Fujian Medical University, Fuzhou, China  2 Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China  \nCorrespondence: Chenghua Yang ([chenghua-yang@qq.com](chenghua-yang@qq.com))  Xu Gao (gaoxu.changhai@foxmail.com)  \nReceived: 18 June 2025  Revised: 21 January 2026  Accepted: 6 February 2026  \nKeywords: B4GALNT4 | glycosylation | PDK1 | PI3K-AKT signaling pathway | prostate cancer  \nABSTRACT  \nAbnormal glycosylation is a hallmark of cancer cells and plays a crucial role in tumor invasion and metastasis. However, the relationship between glycogenes and prostate cancer (PCa) remains poorly understood. This study aims to identify glycogenes involved in the onset and progression of PCa and to investigate the molecular mechanisms underlying their role. By integrating RNA-seq data from multiple clinical cohorts (TCGA and CPGEA) and performing biochemical validation, we identified beta-1,4-Nacetylgalactosaminyltransferase 4 (B4GALNT4) as a glycogene significantly associated with advanced pathological stages, higher Gleason scores, and poor prognosis in PCa patients. Furthermore, multivariate Cox regression analysis confirmed B4GALNT4 as an independent prognostic factor for survival. Mechanistically, we discovered that B4GALNT4 interacts with PDK1 and glycosylates it at residue N531. This N-glycosylation stabilizes PDK1 by blocking its degradation, thereby activating the PI3K-AKT signaling pathway. This signaling axis promotes PCa cell proliferation, migration, and invasion in vitro. Moreover, B4GALNT4 knockdown suppresses tumor growth in xenograft models and correlates with decreased PDK1 and p-AKT levels in vivo. Our findings establish B4GALNT4 as a critical regulator of PCa progression through PDK1 glycosylation and PI3K-AKT activation, suggesting that B4GALNT4 serves as both a prognostic biomarker and a potential therapeutic target for PCa.  \n1  Introduction  \nProstate cancer (PCa) is one of the most common malignancies in men, accounting for approximately 29% of new cancer cases in men in 2024 [1] . Although surgery and radiotherapy provide effective treatment options for patients with localized PCa, the treatment of advanced PCa still faces serious clinical challenges [2] . Androgen deprivation therapy (ADT) is the standard treatment option for advanced PCa, but due to the emergence of  \nADT resistance, 10% to 20% of patients with advanced PCa still progress to castration-resistant prostate cancer (CRPC) within 5 years, resulting in a poor prognosis and a median overall survival (OS) of only about 3 years [3, 4]. Therefore, it is critical to explore new therapeutic targets and develop more effective treatment strategies for PCa.  \nGlycosylation is a widespread post-translational modification regulated by glycosyltransferases (e.g., the B4GALNT family),  \n\n| Shaoqin Jiang, MengqiangLi, Qingfu Su, and Ruiling Dou contributed equally to this work and share the first authorship.\u003Cbr>|\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2026 The Author(s). Advanced Science published by Wiley-VCH GmbH |\n\nAdvanced Science, 2026; 13:e11293  \n[https://doi.org/10.1002/advs.202511293](https://doi.org/10.1002/advs.202511293)  \n1 of 17  \nnucleotide glycosynthesizing enzymes, transport proteins, and glycosidases. It plays a key regulatory role in a variety of physiological and pathological processes [5] . Studies show ","cbCairmx2rXK29oR","https://ap.wps.com/l/cbCairmx2rXK29oR","pdf",12744922,17,"English","# Abstract\n## Introduction\n## Glycosylation and cancer context\n## Study focus on B4GALNT4 and PCa\n## PI3K-AKT signaling pathway background","[{\"question\":\"What question does the study address about prostate cancer?\",\"answer\":\"The study examines which glycogenes are involved in the onset and progression of prostate cancer and clarifies the molecular mechanisms underlying their roles.\"},{\"question\":\"How was B4GALNT4 identified as clinically relevant?\",\"answer\":\"By integrating RNA-seq data from TCGA and CPGEA and performing biochemical validation, B4GALNT4 was found to associate with advanced pathological stages, higher Gleason scores, and poor prognosis, and multivariate Cox regression confirmed it as an independent prognostic factor.\"},{\"question\":\"What mechanism links B4GALNT4 to PI3K-AKT activation?\",\"answer\":\"B4GALNT4 interacts with PDK1 and glycosylates it at residue N531. This N-glycosylation stabilizes PDK1 by blocking its degradation, thereby activating the PI3K-AKT signaling pathway.\"}]","B4GALNT4-Mediated Glycosylation of PDK1 Activates the PI3K-AKT Signaling Pathway to Promote Prostate Cancer Progression | PDF",1790119878,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ff6d82555b0530cb0db554683460d24.webp",983,1283,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6b4388f2734882cbeccb54047e35a28.webp",982,1281,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/758017e1495164e52e844f3a2843e03f.webp",981,1280,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/14017aac26e8ec50fd9ad9537ff4795e.webp",980,1279]